Beyond the Elevator Pitch | Inside Start-up Stories | Part 6

What if we could make cutting-edge cell therapies accessible to all, regardless of financial status? ๐ŸŒ

CYTEA BIO is turning this vision into reality.

As HeadhunterAngels, we celebrate innovative biotech startups that are making a difference. Today, we’re excited to introduce CYTEA BIO, a Swiss-French biotech company based in Montpellier:

CYTEA BIO is addressing the urgent need for affordable and scalable cell therapies. Their groundbreaking ๐๐ข๐งโ„ข ๐๐ฅ๐š๐ญ๐Ÿ๐จ๐ซ๐ฆ enables the production of powerful antibody-cell conjugates, revolutionizing treatments for cancers and immune diseases.

Key innovations include:

๐Ÿงฌ Modular ๐๐ข๐งโ„ข ๐๐ฅ๐š๐ญ๐Ÿ๐จ๐ซ๐ฆ: creating flexible, powerful treatments for oncology and immunology.

๐Ÿงช Affordable solutions: reducing the costs of cell therapies, making them more accessible.

๐Ÿ’‰ High-efficacy treatments: enhancing patient outcomes with minimal side effects.

๐ŸŒ Global impact: offering hope to patients worldwide, irrespective of wealth.

๐Ÿ“– Read the full interview with COO Marc CRITON and learn more about how CYTEA BIO is transforming the future of cell therapy!

 

Startup_presentation_CYTEA